Transaktioner i porteføljen post Alstom

Alstom genkøbte 97 aktier à 35€, hvilket gav porteføljen et kontant provenue på 24.980 kroner. De resterende 205 aktier søger vi at sælge henover 1. kvartal således at vores samlede afkast på investeringen rammer de 10%. Alstom casen tog en del længere tid om at udfolde sig, men givet at markedet generelt er gået pænt ned i januar er det relative afkast …

Read more.

---

Ugens Play: opportunistisk 4. feb

Efter EuroNav´s meget stærke regnskab, som til fulde bekræftede at Q4 2015 realiserede  stærke rater og at disse rater var fortsat i Q1, så er der en mulighed for at spille opportunistisk på et andet selskab i den kommende uge. Afhængig af timingen af vores Alstom payout (som bliver 31-39% af beholdningen solgt til €35) så har vi noget cash vi godt …

Read more.

---
Blackstone AUM

Blackstone rapporterer rekord udbytte og AUM

I går kom Blackstone, verdens største Fundmanager, med regnskab og den viste som ventet stor fremgang i midler under forvaltning, AUM, (Brutto inflow af 15,5 milliarder $ i kvartalet). AUM er den primære driver til sikker indtjening i Blackstone. Man tjener udover performance fee i sine fonde også et fast management fee af summen af midler under forvaltning. Af nedenstående kan …

Read more.

The gateway to small- and midcap stocks in Scandinavia. Steen has more than 15 years hands-on expericence in analysing and investing in stocks. He is a weekly contributor and analyst in “Aktieugebrevet”, one of the leading sources of independent analysis in Denmark.

Peter Hildebrandt, also known as “Akademikeren”, has been investing for more than 17 years. Mainly invests in Undervalued technology and biotech stocks and is currently rotating towards dividend stocks in energy and shipping.

I’m a ten year veteran of biotechnology, and currently pursuing my MBA from UCLA.  I use my knowledge of the industry and business to make my investing decisions.  I look for small to mid-cap biotech companies with innovative research and buy into their company during clinical trials.

Andreas is providing stock tips with deep fundamental research behind each stock he recommends. He is privately a portfolio manager at his own Investment company where he Invest in stocks, options, CFD’s etc. with a balanced long/short approach.

Jacob’s approach is to search for that which is undervalued and where the discount to the intrinsic value provides a large margin of safety. He believes sectors that are either out of favor or in distress typically offer the best opportunities.